Stroke Research

Stroke is classified as both a neurological and a cardiovascular disease, as it is a disruption in blood supply to the brain which causes the neurological abnormalities. There are two types of stroke; ischemic and hemorrhagic.

Stroke Research Products Targets

Adenosine A2B Receptor (7)
Adenosine A2A Receptor (11)
Caspase (9)
Voltage-gated Sodium (NaV) Channel (30)
Voltage-gated Potassium (KV) Channel (38)
Voltage-gated Calcium Channel (CaV) (38)
Lipoxygenase (8)
Others (20)
Cyclooxygenase (24)
Epithelial Sodium Channel (3)
STIM-Orai Channel (4)
Ryanodine Receptor (6)
Natriuretic Peptide Receptor (4)
5-HT7 Receptor (11)
5-HT6 Receptor (14)
5-ht5 Receptor (2)
5-HT4 Receptor (17)
Glutamate (Metabotropic) Group III Receptor (26)
Glutamate (Metabotropic) Group II Receptor (33)
Glutamate (Metabotropic) Group I Receptor (54)
AMPA Receptor (45)
GABAA-ρ Receptor (8)
GABAA Receptor (66)
NMDA Receptor (87)
Kainate Receptor (22)
IP3 Receptor (2)
Glutamate Transporter (18)
Adenosine A3 Receptor (8)
Adenosine A1 Receptor (12)
Acid-Sensing Ion Channel (3)
Calcium-Activated Potassium (KCa) Channel (19)
Calcium-Sensitive Protease Modulator (12)
Inward Rectifier Potassium (Kir) Channel (21)
NO donors and precursors (9)
nNOS (5)
iNOS (11)
eNOS (1)
Prostanoid Receptor (24)

Products for Stroke Research - Page 40

Cat.No. Product Name Information/Activity
BCC7053 CGP 39551 127910-32-1
BCC7087 CGP 78608 hydrochloride CGP 78608 hydrochloride is a highly potent and selective antagonist at the glycine-binding site of the NMDA receptor, with an IC50 of 6 nM. CGP 78608 acts as a potentiator of GluN1/GluN3A-mediated glycine currents, with an estimated EC50 in the low nM range (26.3 nM). Anticonvulsant activity.
BCC6986 CGS 19755 110347-85-8
BCC6805 (2R,3S)-Chlorpheg 140924-23-8
BCC7369 Co 101244 hydrochloride 193356-17-1
BCC6120 Conantokin G 93438-65-4
BCC5980 Conantokin-R 202925-60-8
BCC5977 Conantokin-T 127476-26-0
BCC6581 (R)-CPP 126453-07-4
BCC6561 (RS)-CPP 100828-16-8